J. Mestan

1.5k total citations
7 papers, 515 citations indexed

About

J. Mestan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, J. Mestan has authored 7 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Genetics. Recurrent topics in J. Mestan's work include Ubiquitin and proteasome pathways (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). J. Mestan is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). J. Mestan collaborates with scholars based in Switzerland, United States and Canada. J. Mestan's co-authors include Paul W. Manley, Sandra W. Cowan‐Jacob, Ellen Weisberg, Arghya Ray, James D. Griffin, J M Wood, Stefano Ferrari, Christian Schnell, Z Zhu and Luc de Witte and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. Mestan

7 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mestan Switzerland	5	251	194	190	127	95	7	515
Rosalind H. Gunby Italy	13	267 1.1×	316 1.6×	222 1.2×	141 1.1×	180 1.9×	17	683
Guobao Zhang United States	9	197 0.8×	305 1.6×	124 0.7×	60 0.5×	102 1.1×	15	594
Roberta Rostagno Italy	5	284 1.1×	121 0.6×	227 1.2×	142 1.1×	93 1.0×	6	464
Richard Smykla United States	11	224 0.9×	202 1.0×	165 0.9×	90 0.7×	279 2.9×	16	637
Ryan P. Million United States	11	503 2.0×	340 1.8×	298 1.6×	163 1.3×	193 2.0×	15	944
Sujata Chakraborty United States	10	272 1.1×	286 1.5×	146 0.8×	57 0.4×	94 1.0×	17	541
Matthew S. Zabriskie United States	9	416 1.7×	307 1.6×	301 1.6×	113 0.9×	170 1.8×	24	720
Mei-Li Wen United States	9	166 0.7×	94 0.5×	109 0.6×	84 0.7×	120 1.3×	17	333
Christine Flefleh United States	9	139 0.6×	111 0.6×	104 0.5×	80 0.6×	159 1.7×	13	409
Amy Camuso United States	9	162 0.6×	113 0.6×	114 0.6×	84 0.7×	163 1.7×	12	402

Countries citing papers authored by J. Mestan

Since Specialization

Citations

This map shows the geographic impact of J. Mestan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mestan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mestan more than expected).

Fields of papers citing papers by J. Mestan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mestan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mestan. The network helps show where J. Mestan may publish in the future.

Co-authorship network of co-authors of J. Mestan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mestan. A scholar is included among the top collaborators of J. Mestan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mestan. J. Mestan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kawahara, Ei, Tsuyoshi Miyake, Norihiro Matsuura, et al.. (2008). 133 POSTER Discovery of potent and selective focal adhesion kinase inhibitors. European Journal of Cancer Supplements. 6(12). 43–43. 1 indexed citations

2.

Weisberg, Ellen, Paul W. Manley, J. Mestan, et al.. (2006). AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. British Journal of Cancer. 94(12). 1765–1769. 364 indexed citations

3.

Kawahara, Ei, Osamu Ohmori, K. Nonomura, et al.. (2006). 561 POSTER Discovery of a novel FAK inhibitor, NVP-TAE226, and its activities on in vivo and in vitro models. European Journal of Cancer Supplements. 4(12). 170–170. 1 indexed citations

4.

Kawahara, Ei, Osamu Ohmori, K. Nonomura, et al.. (2006). NVP-TAE226, a potent dual FAK/IGF-IR kinase inhibitor, prevents breast cancer metastasis in vivo. Journal of Clinical Oncology. 24(18_suppl). 13163–13163. 8 indexed citations

5.

Stover, David R., Jennifer Caldwell, Jarrod A. Marto, et al.. (2004). Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts. Clinical Proteomics. 1(1). 69–80. 22 indexed citations

6.

Bold, Guido, Pascal Furet, Paul W. Manley, et al.. (2002). CGP 79787D (PTK787/ZK222584), CGP 84738, NVP-AAC789, NVP-AAD777 and related 1-anilino-(4-pyridylmethyl)phthalazines as inhibitors of VEGF- and bFGF-induced angiogenesis. Drugs of the Future. 27(1). 43–43. 15 indexed citations

7.

Wood, J M, Stefano J. Mandriota, Christian Schnell, et al.. (2001). Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro. Journal of Pharmacology and Experimental Therapeutics. 299(3). 1073–1085. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact